Dpc

1. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee.
Infect Control Hosp Epidemiol. 1999;20:250-278.
2. Misteli H, Weber WP, Reck S, et al. Surgical glove perforation and the risk of surgical site infection. Arch Surg.2009;144:553-558. 3. Carlo A. The new era of flash sterilization. AORN J. 2007;86:58-68. 4. Kjonniksen I, Andersen BM, Sondenaa VG, Segadal L. Preoperative hair removal-a systematic literature review. AORN J. 2002;75:928-938, 940. 5. Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med. 1996;334:1209-1215. 6. Myles PS, Iacono GA, Hunt JO, et al. Risk of respiratory complications and wound infection in patients undergoing ambulatory surgery: smokers versus non- smokers. Anesthesiology. 2002;97:842-847. 7. Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med. 2002;346:1871-1877. 8. Talbot TR. Diabetes mellitus and cardiothoracic surgical site infections. Am J Infect Control. 2005;33:353-359. 9. Latham R, Lancaster AD, Covington JF, et al. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients.
Infect Control Hosp Epidemiol. 2001;22:607-612. 10. Devaney L, Rowell KS. Improved surgical wound classification-why it matters. AORN J. 2004;80:208-299, 212-223. 11. Kourbatova EV, Halvosa JS, King MD, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Am J Infect Control. 2005;33:385-391. 12. Finkelstein R, Rabino G, Mashiah T, et al. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resist- ant staphylococcal infections. J Thorac Cardiovasc Surg. 2002;123:326-332. 13. Garey KW, Lai D, Dao-Tran TK, et al. Interrupted time series analysis of vancomycin compared to cefuroxime for surgical prophylaxis in patients undergoing cardiac surgery. Antimicrob Agents Chemother. 2008;52:446-451. 14. Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis. 2006;43:322-330. 15. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis.
16. Forse RA, Karam B, MacLean LD, Christou NV. Antibiotic prophylaxis for surgery in morbidly obese patients. Surgery. 1989;106:750-756. 17. McDonald M, Grabsch E, Marshall C, Forbes A. Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. Aust N Z J 18. Harbarth S, Samore MH, Lichtenberg D, Carmeli Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation. 2000;101:2916-2921. 19. Sandoe JA, Kumar B, Stoddart B, et al. Effect of extended perioperative antibiotic prophylaxis on intravascular catheter colonization and infection in cardio- thoracic surgery patients. J Antimicrob Chemother. 2003;52:877-879. 20. Edwards FH, Engelman RM, Houck P, et al. The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part I: Duration. Ann Thorac Surg. 2006;81:397-404. 21. Bennett-Guerrero E, Ferguson Jr. TB, Lin M, et al. Effect of an implantable gentamicin-collagen sponge on sternal wound infections following cardiac surgery.
22. Bennett-Guerrero E, Pappas TN, Koltun WA, et al. Gentamicin-collagen sponge for infection prophylaxis in colorectal surgery. N Engl J Med. 23. Darouiche RO, Wall Jr. MJ, Itani KMF, et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med. 2010;362;18-26. 24. Alexander JW, Fischer JE, Boyajian M, et al. The influence of hair-removal methods on wound infections. Arch Surg. 1983;118:347-352. 25. Zerr KJ, Furnary AP, Grunkemeier GL, et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg.
26. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67:352-360. 27. Lindstrom D, Azodi OS, Wladis A, et al. Effects of a perioperative smoking cessation intervention on postoperative complications: a randomized trial. Ann 28. Greif R, Akca O, Horn EP, et al. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. Outcomes Research Group. N Engl 29. Pryor KO, Fahey TJ, 3rd, Lien CA, Goldstein PA. Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a ran- domized controlled trial. JAMA. 2004;291:79-87. 30. Belda FJ, Aguilera L, Garcia de la Asuncion J, et al. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled 31. Dellinger EP. Increasing inspired oxygen to decrease surgical site infection: time to shift the quality improvement research paradigm. JAMA. 2005;294:2091-2092. 32. Bode LGM, Kluytmans JAJW, Wertheim HFL, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl. J Med. 2010;362:9-17. 33. Harbarth S, Huttner B, Bervaz P, et al. Risk factors for methicillin resistant Staphylococcus aureus surgical site infection. Infect Control Hosp Epidemiol.
34. Bassett HFM, Ferguson WG, Hoffman E, et al. Sources of staphylococcal infection in surgical wound sepsis. J Hygiene. 1963;67:49-57. 35. White A. Increased infection rates in heavy nasal carriers of coagulase-positive staphylococci. Antimicrob Agents Chemother. 1964;1963:667-670. 36. Williams REO, Jevons MP, Shooter RA, et al. Nasal staphylococci and sepsis in hospital patients. Br Med J. 1959;2:658-662. 37. Incidence of surgical wound infection in England and Wales. A report of the Public Health Laboratory Service. Lancet. 1960;2:659-663. 38. McNeill IF, Porter IA, Green CA. Staphylococcal infection in a surgical ward. Br Med J. 1961;2:798-802. 39. Henderson RJ, Williams REO. Nasal disinfection in prevention of postoperative staphylococcal infection of wounds. Br Med J. 1961;2:330-333. 40. Calia FM, Wolinsky E, Mortimer EA Jr, Rammelkamp CH Jr. Importance of the carrier state as a source of Staphylococcus aureus in wound sepsis. J Hygiene.
41. Wenzel RP, Perl TM. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J Hosp Infect. 42. Holton DL, Nicolle LE, Diley D, Bernstein K. Efficacy of mupirocin nasal ointment in eradication Staphylococcus aureus nasal carriage in chronic haemodial- ysis patients. J Hosp Infect. 1991;17:133-137. 43. Konvalinka A, Errett L, Fong IW. Impact of treating Staphylococcus aureus nasal carriers on wound infections in cardiac surgery. J Hosp Infect. 2006;64:162-168. 44. Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med. 2002;346:1871-1877. 45. Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis. 2002;35:353-358. 46. Wilcox MH, Hall J, Pike H. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections.
47. Jog S, Cunningham R, Cooper S. Impact of preoperative screening for methicillin-resistant Staphylococcus aureus by real-time polymerase chain reaction in patients undergoing cardiac surgery. J Hosp Infect. 2008;69:124-130. 48. Laupland KB, Conly JM. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Clin Infect Dis. 2003;37:933-938. 49. Trautmann M, Stecher J, Hemmer W, et al. Intranasal mupirocin prophylaxis in elective surgery. Chemotherapy. 2008;54:9-16. 50. Rijen MML, Bonten M, Wenzel RP, Kluytmans JA. Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal car- riage: a systematic review. J Antimicrobial Chemo. 2008;61:254-261. 51. Harbarth S, Fankhauser C, Schrenzel J, et al. Universal Screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infec- tion in surgical patients. JAMA. 2008;299:1149-1157. 52. Segers P, Speekenbrink RG, Ubbink DT, et al. Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidene gluconate: a randomized controlled trial. JAMA. 2006;296:2460-2466. 53. Huizinga WK, Kritzinger NA, Bhamjee A. The value of adjuvant systemic antibiotic therapy in localized wound infections among hospital patients: a com- parative study. J Infect. 1986;13:11- 16. 54. Stevens DL, Bisno AL, Chambers HF, et al. Practice Guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis.

Source: http://www.jhcape.com/site/downloads/Rice_references.pdf